se of Shenhuang Paste on Shenque Point Improves Chemotherapy Induced Gastrointestinal Toxicity in breast Cancer: a Randomized Controlled Trial.
- Conditions
- Breast Cancer
- Registration Number
- ITMCTR2000003442
- Lead Sponsor
- Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
1. Patients aged 40-60 years, KPS score >= 60 points, WBC >= 4.0 * 10^9L-1 before treatment, normal liver and renal function, expected survival > 3 months;
2. All were pathologically confirmed breast cancer patients who met the CLINICAL practice guidelines for NCCN breast cancer (2018.v1) after modified radical mastectomy and received chemotherapy with AC regimen (adriamycin + cyclophosphamide) or TAC regimen (docetaxel + adriamycin + cyclophosphamide) for the first time.
3. It conforms to the provisions of Standard of Curative Effect of Diagnosis of Diseases and Syndromes of Traditional Chinese Medicine and Guiding Principles for Clinical Research of New Chinese Medicines;
4. All the selected patients have signed informed consent and are willing to accept the treatment of this program.
1. Other complications and liver and kidney dysfunction;
2. patients receiving other traditional Chinese medicine intervention (such as taking traditional Chinese medicine, traditional Chinese medicine application, etc.);
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Condition of defecation;
- Secondary Outcome Measures
Name Time Method Analysis of fecal flora and metabolites;hemanalysis;